Search Results - "Katayama, Shiro"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    Acute Kidney Injury in Non-Intensive Care and Intensive Care Patients Treated with Vancomycin and Piperacillin-Tazobactam by Inage, Shunsuke, Nakamura, Shotaro, Isoe, Yuto, Okamoto, Saori, Uetake, Sho, Murakami, Misato, Yamaguchi, Ayaka, Morishima, Masayo, Nei, Takahito, Ise, Yuya, Katayama, Shiro

    Published in Journal of Nippon Medical School (15-04-2020)
    “…Background: We investigated the incidence of acute kidney injury (AKI) and risk factors associated with vancomycin (VAN) and piperacillin-tazobactam (TZP)…”
    Get full text
    Journal Article
  2. 2

    Pregabalin prescription for terminally ill cancer patients receiving specialist palliative care in an acute hospital by Yajima, Ryo, Matsumoto, Kazuaki, Ise, Yuya, Suzuki, Norihito, Yokoyama, Yuta, Kizu, Junko, Katayama, Shiro

    “…Pregabalin is recommended as an adjuvant analgesic for neuropathic cancer-related pain, and may be taken at all steps of the World Health Organization…”
    Get full text
    Journal Article
  3. 3

    Acute Kidney Injury in Non-Intensive Care and Intensive Care Patients Treated with Vancomycin and Piperacillin-Tazobactam by Shunsuke Inage, Shotaro Nakamura, Yuto Isoe, Saori Okamoto, Sho Uetake, Misato Murakami, Ayaka Yamaguchi, Masayo Morishima, Takahito Nei, Yuya Ise, Shiro Katayama

    Published in Journal of Nippon Medical School (01-04-2020)
    “…Background: We investigated the incidence of acute kidney injury (AKI) and risk factors associated with vancomycin (VAN) and piperacillin-tazobactam (TZP)…”
    Get full text
    Journal Article
  4. 4

    Cost-effectiveness analysis comparing carboplatin and weekly paclitaxel with cisplatin and docetaxel in the treatment of advanced non-small cell lung carcinoma by Inage, Shunsuke, Ise, Yuya, Obayashi, Masahiko, Katayama, Shiro, Gemma, Akihiko

    Published in Gan to kagaku ryoho (01-11-2010)
    “…Carboplatin plus weekly paclitaxel (CBDCA/wPTX) and cisplatin plus docetaxel (CDDP/DTX) are the standard regimens used in the first-line treatment of advanced…”
    Get more information
    Journal Article
  5. 5
  6. 6

    フレーバー添加レバミピド内用液剤の安定性に関する基礎検討 by 矢島, 領, 今岡, 楓太, 輪湖, 哲也, 黒田, 裕子, 松元, 一明, 木津, 純子, 片山, 志郎

    Published in YAKUGAKU ZASSHI (01-12-2015)
    “…「緒言」 化学療法及び放射線療法に伴って発症する口内炎はQOLの低下, 経口摂取困難による栄養障害, 治療の中断を招く恐れがある. がん化学療法による口内炎の発生機序は明確ではなく, 抗がん剤などにより生じた活性酸素による一次性の口内炎と,…”
    Get full text
    Journal Article
  7. 7

    Development of new mixing method of Busulfex injection for the purpose of improvement of medical safety method: the prefilled syringe method by Senoo, Makoto, Tajika, Kenji, Shimizu, Hisanori, Hamada, Masaki, Dobashi, Yasuo, Dobashi, Akira, Dan, Kazuo, Katayama, Shiro

    Published in Yakugaku zasshi (01-06-2009)
    “…Busulfex is a new type of busulfan which can be administered intravenously. Usually it is administered over 2 hours every 6 hours. Its injection should be…”
    Get full text
    Journal Article
  8. 8

    Pharmacokinetic and pharmacodynamic studies of pregabalin suppositories based on pharmacological research by Yajima, Ryo, Matsumoto, Kazuaki, Yokono, Kanako, Watabe, Yuki, Enoki, Yuki, Taguchi, Kazuaki, Ise, Yuya, Katayama, Shiro, Kizu, Junko

    Published in Journal of pharmacy and pharmacology (01-05-2019)
    “…Objectives As commercially available pregabalin preparations are limited to oral administration, it is impossible to use it as an adjuvant analgesic for…”
    Get full text
    Journal Article
  9. 9

    医療安全を指向したプレフィルドシリンジ化によるブスルフェクス®注の混合調製方法の開発 by 瀬尾, 誠, 田近, 賢二, 清水, 久範, 浜田, 真向, 土橋, 保夫, 土橋, 朗, 檀, 和夫, 片山, 志郎

    Published in YAKUGAKU ZASSHI (01-06-2009)
    “…「緒言」高用量ブスルファンは同種造血幹細胞移植や自家造血幹細胞移植の前治療に用いられている. 従来経口投与が行われてきたが, 1,2)消化管からの吸収に個人差があり, 至適血中濃度域から逸脱した場合の生着不全や再発, 臓器障害発症が懸念されていた. 3,4)2006年10月, ブスルファンを主成分とする注射液,…”
    Get full text
    Journal Article
  10. 10

    Acute kidney injury in non-intensive care unit and intensive care unit patients treated with vancomycin and piperacillin-tazobactam by Inage, Shunsuke, Nakamura, Shotaro, Isoe, Yuto, Okamoto, Saori, Uetake, Sho, Murakami, Misato, Yamaguchi, Ayaka, Morishima, Masayo, Nei, Takahito, Ise, Yuya, Katayama, Shiro

    Published in Journal of Nippon Medical School (2019)
    “…Background: We investigated the incidence of acute kidney injury (AKI) and the risk factors associated with vancomycin (VAN) and piperacillin-tazobactam (TZP)…”
    Get full text
    Journal Article
  11. 11

    Basic Studies on the Stability of Flavored Oral Solutions of Rebamipide by Yajima, Ryo, Imaoka, Futa, Wako, Tetsuya, Kuroda, Yuko, Matsumoto, Kazuaki, Kizu, Junko, Katayama, Shiro

    Published in YAKUGAKU ZASSHI (01-12-2015)
    “…Stomatitis frequently occurs during chemotherapy and radiotherapy for cancer. Because of its pharmacological properties including anti-inflammatory activity…”
    Get full text
    Journal Article
  12. 12
  13. 13

    胃切除患者クリニカルパスの薬剤経済学的評価 by 伊勢, 雄也, 本城, 和義, 宋, 静香, 瀬尾, 誠, 片山, 志郎, 平野, 公晟, 三橋, 恭子, 吉行, 俊郎, 木山, 輝郎

    Published in Journal of Nippon Medical School (2003)
    “…医療の質の確保と標準化, 効率化, ならびに高騰する医療費の節減を目指してクリニカルパス(以下CPと略す)を導入する施設が年々増加してきている. 当病院では1998年に「CP研究会」が病院管理学教室, 第一外科学教室, 麻酔科学教室および看護部により設立され,…”
    Get full text
    Journal Article
  14. 14

    Development of New Mixing Method of Busulfex® Injecton for the Purpose of Improvement of Medical Safety Method; The Prefilled Syringe Method by SENOO, Makoto, TAJIKA, Kenji, SHIMIZU, Hisanori, HAMADA, Masaki, DOBASHI, Yasuo, DOBASHI, Akira, DAN, Kazuo, KATAYAMA, Shiro

    Published in YAKUGAKU ZASSHI (01-06-2009)
    “…Busulfex®is a new type of busulfan which can be administered intravenously. Usually it is administered over 2 hours every 6 hours. Its injection should be…”
    Get full text
    Journal Article
  15. 15

    Pharmacoeconomical Evaluation of Clinical Pathway in Gastrectomy Patients by Ise, Yuya, Honjo, Kazuyoshi, So, Shizuka, Senoo, Makoto, Katayama, Shiro, Hirano, Masaaki, Mitsuhashi, Kyoko, Yoshiyuki, Toshiro, Kiyama, Teruo

    Published in Journal of Nippon Medical School (2003)
    “…The aim of the present study was to ascertain the pharmacoeconomical efficacy of a clinical pathway (CP) employing medication management and instruction tasks…”
    Get full text
    Journal Article